Marth C, Lang T, Koza A, Mayer I, Daxenbichler G
Department of Obstetrics and Gynecology, Innsbruck University Clinic, Austria.
Cancer Lett. 1990 Jun 15;51(3):221-5. doi: 10.1016/0304-3835(90)90106-8.
Transforming growth factor-beta (TGF-beta) is a multifunctional peptide regulating several processes in ovarian cells. The growth of ovarian carcinoma cell lines (OVCAR-3, HTB-77, 2780 and CRL-1572) was reduced by TGF-beta in a dose related manner. The antiproliferative activity was not improved by combination with other biological response modifiers. Treatment with TGF-beta augmented the expression of interferon-gamma induced class I and II antigens of the major histocompatibility complex. The presentation of another antigen namely the tumor marker CA-125 on the cell surface was markedly reduced by TGF-beta.
转化生长因子-β(TGF-β)是一种多功能肽,可调节卵巢细胞中的多个过程。TGF-β以剂量相关的方式降低了卵巢癌细胞系(OVCAR-3、HTB-77、2780和CRL-1572)的生长。与其他生物反应调节剂联合使用并不能提高其抗增殖活性。TGF-β处理可增强主要组织相容性复合体的I类和II类干扰素-γ诱导抗原的表达。TGF-β可显著降低细胞表面另一种抗原即肿瘤标志物CA-125的表达。